Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostatic Diseases × Lutetium-177 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Urogenital Neoplasms 1 Prostatic Diseases 1 Neuroendocrine Tumors 1 Carcinoma, Merkel Cell 1 Carcinoma 1

Interventions

Abiraterone Acetate 2 onapristone 1 olaparib 1 gedatolisib 1 darolutamide 1 abiraterone 1 Radiotherapy 1 Pluvicto 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 EPI-506 1 Brachytherapy 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05413850 2026-03-02

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Blue Earth Therapeutics Ltd

Phase 1/2 Recruiting

Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡